CAPR vs SPY
Capricor Therapeutics Inc (CAPR) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
SPY does not have a complete income-statement cache yet.
CAPR currently screens at market cap $1.62B. SPY currently screens at market cap $0.
Not investment advice. Open the CAPR and SPY stock pages for the full models.
Not investment advice.